Full video transcriptClick to expand
Auto-generated transcript of @ljgfitness's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00Right, so my man's gonna be starting testosterone 200 to 250 milligrams a week and he wants to know when does it the best time to get his blood
- 0:07checked in his cycle. Let me firstly say I hope you got your blood checked before even jumping on and you've assessed your baseline levels of testosterone E2 prolactin as well as checking you haven't got any underlying health conditions such as things with your kidneys, your liver, your heart, and your blood glucose diabetes, things like that.
- 0:25Assess that you've got no issues like that before jumping on in the first place. Now we're gonna assume you've done that already and you know where your test levels are.
- 0:338 to 12 weeks into starting testosterone that's when you want to get your blood checked again and the reason for that is because testosterone is taking 6 weeks to saturate in our system and get us to our level that we're gonna be at on that 200 to 250 milligrams.
- 0:46So, 8 to 12 weeks in you want to get your blood checked again and assuming that nothing is wrong on that 8 to 12 week bloods, you can then continue that cycle up to 20 to 24 weeks and then test again your bloods and if nothing is wrong still at that point and you're in perfect health,
- 1:00you could even continue it longer. However, me personally, I would never do a cycle for longer than 24 weeks before dropping to a TRT health phase, which is TRT only for me.
- 1:10Do that for about 8 to 12 weeks and then jumping onto a second or another cycle. Some guys will PCT or advise you to PCT and strongly advise it against it.
- 1:20It's very hard on the body and if you're providing to get back onto another cycle, there's just no point messing with your hormones that much in my opinion, just for 20 weeks, just for fun to PCT off.
- 1:31So, for me, it's blast and cruise all the way but you guys might disagree with that if you do drop it in the comments. Peace.
TRT and bloodwork claims: what the evidence actually shows
Quick answer
The creator is advising on bloodwork timing for a supraphysiological testosterone cycle of 200-250mg per week, a dose significantly above standard clinical TRT ranges of 75-100mg per week used to treat hypogonadism. While the 8-12 week monitoring window is consistent with Endocrine Society guidance for replacement therapy, it does not account for the broader cardiovascular, hematologic, and hepatic monitoring required at higher doses. The dismissal of PCT in favor of indefinite blast-and-cruise protocols carries long-term fertility and HPG axis implications that are not adequately disclosed.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 9 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For TRT and bloodwork claims: what the evidence actually shows, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
NAD+ metabolism and its roles in cellular processes during ageing
Core review for NAD+ decline, mitochondrial function, DNA repair, and aging biology.
PubMed
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Human NMN source for metabolic claims while keeping population limits clear.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
TRT and bloodwork claims: what the evidence actually shows is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "TRT and bloodwork claims: what the evidence actually shows" from ljgfitness. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The creator is advising on bloodwork timing for a supraphysiological testosterone cycle of 200-250mg per week, a dose significantly above standard clinical TRT ranges of 75-100mg per week used to treat hypogonadism.
The reason this review is not generic is the source wording and the canonical claim label "trt replying to 07 omr great question hope this helps trt testos." In this clip, the useful excerpt is: "Right, so my man's gonna be starting testosterone 200 to 250 milligrams a week and he wants to know when does it the best time to get his blood checked in his cycle." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
The creator is advising on bloodwork timing for a supraphysiological testosterone cycle of 200-250mg per week, a dose significantly above standard clinical TRT ranges of 75-100mg per week used to treat hypogonadism.
FormBlends verdict
Testosterone evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- The creator is advising on bloodwork timing for a supraphysiological testosterone cycle of 200-250mg per week, a dose significantly above standard clinical TRT ranges of 75-100mg per week used to treat hypogonadism. While the 8-12 week monitoring window is consistent with Endocrine Society guidance for replacement therapy, it does not account for the broader cardiovascular, hematologic, and hepatic monitoring required at higher doses. The dismissal of PCT in favor of indefinite blast-and-cruise protocols carries long-term fertility and HPG axis implications that are not adequately disclosed.
- Testosterone cypionate reaches steady-state plasma levels in approximately 5-6 weeks based on its 8-day half-life, making the 8-12 week bloodwork window pharmacokinetically reasonable.
- The Endocrine Society (Bhasin et al., 2018) recommends follow-up labs at 3 months for patients on TRT, but those guidelines cover replacement doses of 75-100mg per week, not supraphysiological cycles.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Testosterone cypionate reaches steady-state plasma levels in approximately 5-6 weeks based on its 8-day half-life, making the 8-12 week bloodwork window pharmacokinetically reasonable.
- The Endocrine Society (Bhasin et al., 2018) recommends follow-up labs at 3 months for patients on TRT, but those guidelines cover replacement doses of 75-100mg per week, not supraphysiological cycles.
- At 200-250mg per week, monitoring should include hematocrit, lipid panels, liver enzymes, and blood pressure, not just testosterone and estradiol.
- Rasmussen et al. (2016) found that HPG axis and spermatogenesis recovery after anabolic steroid use can take years, and some men never fully recover without intervention.
- Coviello et al. (2008) demonstrated dose-dependent HDL cholesterol suppression with supraphysiological testosterone, a cardiovascular risk factor not addressed in the creator's 'bloods look fine' framing.
- Blast-and-cruise protocols mean accepting likely permanent suppression of endogenous testosterone production. This is a significant long-term consequence, not a casual lifestyle choice.
- Anyone using testosterone at any dose should be under the supervision of a licensed healthcare provider who can interpret bloodwork in full clinical context.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @ljgfitness actually say?
The creator advises someone planning to run 200-250mg of testosterone per week to get bloodwork at 8-12 weeks into their cycle, citing that testosterone takes "6 weeks to saturate" the system. They recommend continuing to 20-24 weeks if labs look clean, then either stopping or dropping to what they call a "TRT health phase" before cycling again. They also actively discourage PCT, calling it hard on the body and pointless if you plan to cycle again, endorsing "blast and cruise" as their preferred protocol. A few things here are reasonable. A few are not.
Does the science back this up?
The 8-12 week bloodwork window is broadly defensible, but the reasoning is slightly off. Testosterone cypionate and enanthate reach steady-state plasma concentrations in roughly 4-5 half-lives. Cypionate has a half-life of approximately 8 days, meaning steady state is closer to 5-6 weeks, which the creator roughly captures. The Endocrine Society's 2018 clinical practice guidelines (Bhasin et al., 2018, Journal of Clinical Endocrinology and Metabolism) recommend checking testosterone levels after 3 months of initiating therapy, which aligns with the 8-12 week window. However, those guidelines are written for hypogonadal patients on replacement doses, not supraphysiological cycles of 200-250mg per week. At those doses, hematocrit, lipid panels, liver enzymes, and cardiovascular markers become far more pressing than just testosterone and estradiol. A single bloodwork check at 8-12 weeks on a supraphysiological dose is the floor, not the ceiling.
What did they get wrong (or right)?
Credit where it's due: recommending baseline bloodwork before starting, checking kidney function, liver markers, blood glucose, and cardiac health is genuinely good advice, and more thorough than most TikTok testosterone content. The 8-12 week timing for re-checking levels is defensible from a pharmacokinetic standpoint.
Where this falls apart is the blast-and-cruise recommendation and the dismissal of PCT. The creator says PCT is "very hard on the body" and discourages it if someone plans to cycle again. That framing is doing a lot of work. PCT exists to restore hypothalamic-pituitary-gonadal axis function. Choosing blast-and-cruise permanently means accepting that your endogenous testosterone production will not recover, likely ever. Research by Rasmussen et al. (2016, Journal of Clinical Endocrinology and Metabolism) found that recovery of spermatogenesis and HPG axis function after anabolic steroid use can take months to years, and some men never fully recover. Telling a general audience to skip PCT and just cruise on exogenous testosterone indefinitely is a significant commitment that the creator presents as a casual lifestyle preference.
The 200-250mg per week dose also sits well above standard TRT ranges. Most clinical protocols for hypogonadism use 75-100mg per week. This is a cycle, not TRT, and framing the monitoring advice as routine bloodwork obscures the actual risk profile.
What should you actually know?
If you are on a physician-supervised TRT protocol at standard doses, 8-12 weeks for follow-up bloodwork is reasonable and consistent with clinical guidelines. But the monitoring panel matters. Endocrine Society guidelines recommend checking total testosterone, hematocrit, and PSA. At supraphysiological doses, you also need lipids, liver enzymes, blood pressure, and cardiac markers, because polycythemia and dyslipidemia are real risks at higher doses. Coviello et al. (2008, Journal of Clinical Endocrinology and Metabolism) demonstrated dose-dependent suppression of HDL cholesterol with supraphysiological testosterone, a finding that should not be buried under a "bloods look fine" summary.
On PCT: the decision to use it or not carries long-term hormonal consequences that a TikTok comment section should not be resolving. If permanent HPG axis suppression and infertility are acceptable outcomes for you, blast-and-cruise may be a rational choice. But that decision requires full information, ideally from a physician, not a fitness creator on social media.
- Anyone using exogenous testosterone should be under the care of a licensed healthcare provider.
- Bloodwork panels at supraphysiological doses need to include more than just testosterone and estradiol.
- The 8-12 week timing is reasonable, but it is a starting point, not the full picture.
- Blast-and-cruise is not a safe default recommendation for a general audience.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
ljgfitness · TikTok creator
6.8K views on this video
Replying to @07.omr great question hope this helps #trt #testosterone #bloodwork #hormones #menshealth
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about testosterone cypionate reaches steady-state plasma levels in approximately 5-6 weeks?
Testosterone cypionate reaches steady-state plasma levels in approximately 5-6 weeks based on its 8-day half-life, making the 8-12 week bloodwork window pharmacokinetically reasonable.
What does the video say about the endocrine society (bhasin et al., 2018) recommends follow-up labs?
The Endocrine Society (Bhasin et al., 2018) recommends follow-up labs at 3 months for patients on TRT, but those guidelines cover replacement doses of 75-100mg per week, not supraphysiological cycles.
What does the video say about at 200-250mg per week, monitoring should include hematocrit, lipid panels,?
At 200-250mg per week, monitoring should include hematocrit, lipid panels, liver enzymes, and blood pressure, not just testosterone and estradiol.
What does the video say about rasmussen et al. (2016) found?
Rasmussen et al. (2016) found that HPG axis and spermatogenesis recovery after anabolic steroid use can take years, and some men never fully recover without intervention.
What does the video say about coviello et al. (2008) demonstrated dose-dependent hdl cholesterol suppression with?
Coviello et al. (2008) demonstrated dose-dependent HDL cholesterol suppression with supraphysiological testosterone, a cardiovascular risk factor not addressed in the creator's 'bloods look fine' framing.
What does the video say about blast-and-cruise protocols mean accepting likely permanent suppression of endogenous testosterone?
Blast-and-cruise protocols mean accepting likely permanent suppression of endogenous testosterone production. This is a significant long-term consequence, not a casual lifestyle choice.
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by ljgfitness, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.